| Literature DB >> 29973572 |
Oto Hanuš1, Eva Samková2, Ludmila Křížová3, Lucie Hasoňová4, Robert Kala5.
Abstract
Fatty acids (FAs) of milk fat are considered to be important nutritional components of the diets of a significant portion of the human population and substantially affect human health. With regard to dairy farming, the FA profile is also seen as an important factor in the technological quality of raw milk. In this sense, making targeted modifications to the FA profile has the potential to significantly contribute to the production of dairy products with higher added value. Thus, FAs also have economic importance. Current developments in analytical methods and their increasing efficiency enable the study of FA profiles not only for scientific purposes but also in terms of practical technological applications. It is important to study the sources of variability of FAs in milk, which include population genetics, type of farming, and targeted animal nutrition. It is equally important to study the health and technological impacts of FAs. This review summarizes current knowledge in the field regarding sources of FA variability, including the impact of factors such as: animal nutrition, seasonal feed changes, type of animal farming (conventional and organic), genetic parameters (influence of breed), animal individuality, lactation, and milk yield. Potential practical applications (to improve food technology and consumer health) of FA profile information are also reviewed.Entities:
Keywords: breed; dairy cow; energy status; feeding; genetic polymorphism; lactation; milk fatty acid profile; nutrition; organic system; season
Mesh:
Substances:
Year: 2018 PMID: 29973572 PMCID: PMC6100482 DOI: 10.3390/molecules23071636
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Diagram of the sources of variability in the fatty acid profile of milk.
Effects of the types of forage and oilseed on the proportion of fatty acids (FAs; % of total FA) in milk fat *.
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
| Silage | |||||||||||
| - grass | 12.4 (11) | 32.3 (13) | 9.8 (13) | 16.1 (13) | 1.18 (6) | 1.18 (13) | 0.54 (6) | 0.49 (13) | 48.6 (11) | 18.5 (10) | 3.65 (10) |
| - legume | 11.0 (6) | 27.6 (6) | 9.9 (6) | 17.6 (6) | 1.24 (5) | 1.69 (6) | 0.51 (5) | 0.95 (6) | 42.1 (6) | 19.7 (6) | 3.53 (6) |
| - mix 1 | 11.2 (5) | 32.1 (5) | 10.3 (5) | 18.8 (4) | 0.83 (4) | 1.43 (5) | 0.47 (4) | 0.48 (5) | 46.6 (5) | 18.2 (1) | 2.34 (3) |
| - corn | 13.4 (6) | 33.2 (8) | 7.0 (8) | 16.7 (8) | 0.92 (7) | 1.92 (8) | 0.45 (7) | 0.39 (8) | 51.8 (6) | 18.9 (6) | 2.30 (1) |
| Pasture | 10.1 (18) | 25.0 (20) | 9.6 (20) | 19.7 (20) | 3.15 (20) | 1.04 (17) | 1.30 (20) | 0.75 (17) | 38.1 (18) | 21.1 (13) | 4.25 (7) |
| Oilseeds | |||||||||||
| - soybean | 11.2 (4) | 29.4 (4) | 10.8 (4) | 16.8 (4) | 0.99 (3) | 3.01 (4) | 0.66 (4) | 0.45 (4) | 43.9 (4) | ||
| - rapeseed | 10.8 (6) | 28.5 (6) | 12.5 (6) | 21.2 (6) | 1.28 (3) | 2.26 (5) | 0.75 (5) | 0.41 (6) | 42.2 (6) | 25.0 (1) | 6.4 (1) |
| - mix 2 | 11.3 (3) | 33.5 (3) | 10.4 (3) | 21.4 (3) | 2.64 (3) | 0.55 (2) | 0.3 (3) | 48.1 (3) | |||
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
| ||
| Silage | |||||||||||
| - grass | 1.67 (13) | 1.33 (10) | 0.51 (10) | 27.6 (13) | 2.82 (10) | 2.77 (10) | 1.77 (11) | 3.58 (10) | 0.62 (16) | 0.50 (13) | |
| - legume | 2.64 (6) | 2.09 (6) | 1.20 (6) | 30.1 (6) | 2.49 (6) | 1.95 (6) | 1.41 (6) | 2.83 (6) | 0.64 (6) | 0.64 (6) | |
| - mix 1 | 1.91 (5) | 1.97 (4) | 0.68 (4) | 30.3 (4) | 2.89 (1) | 2.98 (4) | 1.59 (4) | 3.46 (4) | 0.65 (4) | 0.59 (4) | |
| - corn | 2.31 (8) | 2.43 (5) | 0.43 (5) | 26.0 (8) | 3.03 (6) | 6.21 (5) | 2.09 (6) | 3.82 (5) | 0.70 (8) | 0.50 (8) | |
| Pasture | 1.79 (17) | 1.56 (14) | 0.99 (14) | 30.5 (17) | 2.36 (10) | 1.69 (14) | 1.33 (15) | 2.45 (13) | 0.67 (20) | 0.79 (20) | |
| Oilseeds | |||||||||||
| - soybean | 3.45 (4) | 4.08 (2) | 1.64 (2) | 32.5 (4) | 2.24 (4) | 2.49 (2) | 1.45 (4) | 2.52 (4) | 0.67 (4) | 0.75 (4) | |
| - rapeseed | 2.29 (6) | 2.17 (5) | 1.02 (5) | 37.3 (6) | 1.79 (6) | 1.71 (5) | 1.20 (6) | 2.17 (6) | 0.67 (6) | 0.92 (6) | |
| - mix 2 | 2.95 (3) | 2.88 (3) | 0.76 (3) | 35.1 (3) | 2.1 (2) | 3.79 (3) | 1.39 (3) | 1.90 (3) | 0.68 (3) | 0.67 (3) |
* Values for forages calculated from 15 publications [46], values for oilseeds calculated from eight publications [22,27,32,33,55,56,57,58]; mix from various proportions of corn and grass silages; 2 mix of oilseeds (rapeseed + soybean or rapeseed + sunflower); HFA—hypercholesterolaemic FAs (∑ C12:0, C14:0 and C16:0); 3 C18—(∑ C18:0, C18:1 c9, 18:2 n-6 and 18:3 n-3); 4 c-MUFA—cis-isomers of monounsaturated FAs (∑ C14:1 c9, C16:1 c9 and C18:1 c9); 5 t-MUFA—trans-isomers of monounsaturated FAs C18:1, including C18:1 t11; 6 EFA—essential FAs (∑ C18:2 n-6 and C18:3 n-3); 7 PUFA—polyunsaturated FAs, n-6 and n-3; 8 SFA/UFA—saturated/unsaturated FA ratio; 9 AI—atherogenic index [(C12:0 + 4 × C14:0 + C16:0)/(∑MUFA + ∑(n-6) + ∑(n-3))], DI—desaturation index [C18:1 c9/(C18:0 + C18:1 c9)], SI—spreadability index [C18:1 c9/C16:0].
Proportions of some fatty acids (FAs) and their groups in bovine milk fat (g 100 g−1 of FA) depending on rearing type *.
| Conventional Herds | Organic Herds | |||
|---|---|---|---|---|
| Mean |
| Mean |
| |
| C18:2 n-6 | 2.74 | 2 | 2.39 | 3 |
| C18:3 n-3 | 0.51 | 6 | 1.85 | 8 |
| C18:1 | 1.82 | 5 | 2.74 | 7 |
| C18:2 | 0.64 | 9 | 0.91 | 11 |
| SFA 1 | 68.2 | 7 | 68.3 | 9 |
| MUFA 2 | 26.8 | 7 | 27.0 | 9 |
| PUFA 3 | 4.39 | 7 | 4.91 | 9 |
| PUFA n-6 3 | 2.54 | 6 | 2.03 | 7 |
| PUFA n-3 3 | 0.76 | 4 | 0.87 | 4 |
| S/U 4 | 2.19 | 7 | 2.17 | 9 |
| n-6/n-3 3 | 4.29 | 5 | 2.65 | 6 |
* Means and numbers of cases from six publications: [62,63,64,65,66,67]; 1 SFA—saturated FAs; 2 MUFA—monounsaturated FAs; 3 PUFA—polyunsaturated FAs, n-6 and n-3 series and their n-6/n-3 ratio; 4 S/U—ratio between saturated and unsaturated FAs.
Figure 2Proportions of palmitic and oleic acids (g∙100 g−1 of fatty acids) depending on lactation stage. References: A = [100], B = [101], C = [102], D = [103].
Mean and coefficient of variation (CV; %) for milk yield, content of fat, protein, and lactose (g·100 g−1 of milk), and groups of fatty acids (FAs) 1.
| Holstein (Belgium) [ | Holstein (Italy) [ | Holstein (Brazil) [ | ||||
|---|---|---|---|---|---|---|
| Mean | CV | Mean | CV | Mean | CV | |
| Milk yield (kg/day) | 23.1 | 25.9 | 31.6 | 28.5 | 34.2 | 29.5 |
| Fat (g·100 g−1) | 3.96 | 13.7 | 3.70 | 18.9 | 3.45 | 21.7 |
| Protein (g·100 g−1) | 3.34 | 9.7 | 3.40 | 11.8 | 3.05 | 9.9 |
| Lactose (g·100 g−1) | 4.60 | 5.2 | ||||
| Groups of FA (g·100 g−1 of milk (g·100 g−1 of fat)) | ||||||
| SFA | 2.79 (74.17) | 16.5 | 2.58 (73.40) | 20.5 | 2.23 (68.04) | 22.7 |
| UFA | 1.31 (34.79) | 17.3 | 1.11 (31.58) | 21.6 | 1.03 (31.43) | 28.8 |
| MUFA | 1.13 (29.98) | 18.2 | 0.91 (25.89) | 22.0 | 0.87 (26.54) | 30.8 |
| PUFA | 0.17 (4.43) | 19.2 | 0.09 (2.56) | 33.3 | 0.16 (4.88) | 30.8 |
1 SFA—saturated FAs; UFA—unsaturated FAs; MUFA—monounsaturated FAs; PUFA—polyunsaturated FAs.
Overview of heritability, method 1, number of samples (cows and sires), breed 2, and country 3 for selected milk fatty acids (FAs) and their groups 4.
| Reference | Method | g∙100 g−1 | Number of | Breed | Country | Heritability 5 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Samples | Cows | Sires | h2 | MY (kg) | F (%) | FY (kg) | C14:0 | C16:0 | C18:0 | C18:1 | CLA | SFA | UFA | MUFA | PUFA | |||||
| [ | GC | of FA | 592 | 233 | 53 | H | US | h2IH | 0.11 | 0.19 | <0.001 | 0.09 | 0.24 | 0.06 | 0.05 | 0.08 | <0.001 | |||
| [ | MIR-FT | of fat | 52,950 | 3217 | 1666 | H | BE | h2G | 0.20 | 0.33 | 0.15 | 0.15 | 0.16 | 0.17 | ||||||
| [ | GC | of fat | 1918 | 101 | H | NL | h2G | 0.29 | 0.47 | 0.29 | 0.49 | 0.31 | 0.19 | 0.18 | 0.21 | |||||
| GC | of fat | 1918 | 101 | H | NL | h2IH | 0.41 | 0.51 | 0.39 | 0.59 | 0.43 | 0.23 | 0.25 | 0.42 | ||||||
| [ | GC | of fat | 990 | H | IT | 0.07 | 0.03 | 0.08 | 0.17 | 0.12 | 0.14 | |||||||||
| [ | GC | of FA | 2408 | 597 | HF | GB | 0.35 | 0.09 | 0.06 | 0.04 | 0.12 | 0.02 | 0.14 | 0.09 | 0.03 | |||||
| [ | MIR-FT | of milk | 130,285 | 26,166 | H | BE | 0.20 | 0.39 | 0.17 | 0.44 | 0.41 | 0.23 | 0.18 | 0.43 | 0.22 | 0.21 | 0.30 | |||
| [ | MIR-FT | of milk | 143,332 | 29,792 | H | BE | 0.31 | 0.68 | 0.29 | 0.68 | 0.67 | 0.60 | 0.52 | 0.68 | 0.60 | 0.58 | 0.69 | |||
| [ | GC | of fat | 371 | 200 | H | DK | h2G | 0.24 | 0.25 | 0.14 | 0.19 | 0.11 | 0.19 | 0.09 | 0.33 | 0.34 | 0.28 | |||
| [ | GC | of FA | 371 | H | DK | h2G | 0.16 | <0.001 | 0.14 | <0.001 | ||||||||||
| MIR-FT | of FA | 371 | H | DK | h2G | 0.17 | 0.36 | 0.33 | 0.07 | |||||||||||
| [ | MIR-FT | of milk | 72,848 | 17,873 | 1235 | H | IT | h2G | 0.10 | 0.20 | 0.25 | 0.07 | 0.08 | 0.08 | ||||||
| MIR-FT | of milk | 72,848 | 17,873 | 1235 | H | IT | h2IH | 0.14 | 0.24 | 0.29 | 0.09 | 0.10 | 0.15 | |||||||
| [ | GC | of fat | 339 | H | DK | h2P | 0.16 | 0.21 | 0.11 | 0.07 | 0.13 | |||||||||
| GC | of fat | 339 | H | DK | h2G | 0.08 | 0.17 | 0.17 | 0.02 | 0.18 | ||||||||||
| [ | MIR-FT | of milk | 36,457 | 4203 | 226 | H | BR | h2P | 0.26 | 0.13 | 0.07 | 0.25 | 0.08 | 0.07 | 0.11 | |||||
| MIR-FT | of milk | 36,457 | 4203 | 226 | H | BR | h2G | 0.26 | 0.14 | 0.07 | 0.25 | 0.08 | 0.07 | 0.11 | ||||||
| [ | MIR-FT | of milk | 241,236 | 33,555 | H | BE | h2G | 0.42 | 0.38 | 0.19 | 0.15 | 0.40 | 0.20 | 0.19 | ||||||
| [ | MIR-FT | of fat | 612,321 | 132,731 | H | DK | h2IH | 0.09 | 0.14 | 0.11 | 0.13 | 0.15 | 0.15 | 0.08 | ||||||
| MIR-FT | of fat | 95,920 | 21,967 | J | DK | h2IH | 0.07 | 0.16 | 0.09 | 0.10 | 0.10 | 0.10 | 0.11 | |||||||
1 MIR-FT—infrared spectroscopy in mid-range with Fourier transformation; GC—gas chromatography; 2 H—Holstein; HF—Hereford; J—Jersey; 3 BE—Belgium; BR—Brazil; DK—Denmark; GB—Great Britain; IT—Italy; NL—Netherlands; US—the United States; 4 CLA—conjugated linoleic acid; SFA—saturated FAs; UFA—unsaturated FAs; MUFA—monounsaturated FAs; PUFA—polyunsaturated FAs; 5 h2G—genomic; h2IH—intraherd; h2P—pedigree; heritability is estimated based on linear models; the estimate of H2G, H2IH, H2P is different by the number of variables involved (σ2A, σ2E, σ2PEAL, σ2PEWL, etc.); MY—milk yield; F—fat content; FY—fat yield.
Genetic and phenotypic correlations (r) 1 between fat content or milk yield and selected fatty acids (FAs) and their groups.
| Reference | r 1 | C14:0 | C16:0 | C18:0 | C18:1 | CLA | SFA | MUFA | PUFA |
|---|---|---|---|---|---|---|---|---|---|
| Fat Content (g∙100 g−1) | |||||||||
| [ | G | −0.43 | 0.65 | 0.01 | −0.58 | ||||
| P | −0.27 | 0.43 | 0.08 | −0.32 | |||||
| [ | G | 0.06 | 0.17 | −0.14 | −0.26 | 0.34 | −0.33 | −0.26 | |
| P | −0.04 | −0.05 | 0.02 | −0.04 | 0.09 | −0.08 | −0.07 | ||
| [ | G | 0.98 | 0.86 | 0.80 | 0.99 | 0.79 | 0.52 | ||
| P | 0.90 | 0.82 | 0.81 | 0.95 | 0.83 | 0.71 | |||
| [ | G | −0.40 | 0.74 | 0.28 | 0.02 | −0.55 | 0.01 | ||
| [ | G | −0.43 | 0.65 | 0.01 | −0.63 | ||||
| [ | G | 0.84 | 0.88 | 0.71 | 0.64 | 0.91 | 0.72 | 0.69 | |
|
| |||||||||
| [ | G | −0.35 | −0.28 | −0.29 | −0.36 | −0.32 | −0.38 | ||
| P | −0.09 | −0.06 | −0.01 | −0.06 | −0.03 | −0.03 | |||
| [ | G | 0.30 | −0.50 | 0.15 | 0.32 | ||||
| [ | G | −0.34 | −0.33 | −0.30 | −0.31 | −0.36 | −0.35 | −0.37 | |
1 Correlation coefficient; G—genetic; P—phenotypic; CLA—conjugated linoleic acid; SFA—saturated FAs; MUFA—monounsaturated FAs; PUFA—polyunsaturated FAs.
Overview of selected candidate genes coding enzymes that affect bovine milk fat and fatty acids (FAs).
| Reference | Gene | Gene Name | BTA 1 | Polymorphism | Associated with: 2 |
|---|---|---|---|---|---|
| [ |
|
| 2 | A/G transition | fat (↑) and protein (↑) content |
| [ |
|
| 4 | A80V | milk yield (↑) |
| [ |
|
| 6 | Y581S | milk yield (↑), fat (↑) and protein (↑) content |
| [ |
|
| 6 | T19C | fat yield (↑) |
| [ |
|
| 13 | n.a. | activation and intracellular channeling of FAs |
| [ |
|
| 14 | K232A | fat content (↑) |
| [ |
|
| 19 | n.a. | biosynthesis of milk fat (especially C14:0) |
| [ |
|
| 19 | T1950A | fat content (↑), C14:0 (↑) |
| [ |
|
| 19 | GH4.1 GH6.2 | milk (↑), fat (↑) and protein (↑) yield |
| [ |
|
| 19 | A9501G | milk yield (↑), protein content (↑) |
| [ |
|
| 19 | L852P | haplotype H1 – effects on C12:0 (↓) and C14:0 (↓) |
| [ |
|
| 20 | GHR4.2 | milk yield (↑) |
| [ |
|
| 26 | A293V | indices C10 (↓), C12 (↓), C14 (↓), C16 (↑), C18 (↑), CLA (↑) |
| [ |
|
| 27 | n.a. | fat content (↑) |
n.a.—not available ; 1 BTA—Bos taurus autosome; 2 C18u—unsaturated C18; CLA—conjugated linoleic acid; ↑—an increase; ↓—a decrease.
Effects of selected fatty acids (FAs) on human health.
| FA | Role | References |
|---|---|---|
| C4:0 |
beneficial effect on the intestinal flora and human gastrointestinal wall primarily by acting as a direct source of energy for colonocytes one of the factors preventing progression of colorectal cancer and mammary cancer inhibition of cell growth, promotion of differentiation, and induction of apoptosis in various human cancer cell lines may prevent the invasion of tumors via inhibitory effects on urokinase seems to exert broad anti-inflammatory activity by affecting immune cell migration, adhesion, and cytokine expression, as well as affecting cellular processes such as proliferation, activation, and apoptosis | [ |
| C12:0, C14:0, C16:0, C18:0 |
C14:0 and C16:0—increase total blood cholesterol level and increase the risk of cardiovascular diseases C18:0 and C14:0—increase thrombogenicity and cholesterol level C12:0, C14:0, and C16:0, are related to an increased risk of atherosclerosis, hyperlipidemia, and low-density lipoprotein cholesterol, obesity and coronary heart disease | [ |
| BCFA |
BCFA—anti-cancer activity BCFA—reduced risk of necrotizing enterocolitis in newborns BCFA—improvement of β-cell function iso C15:0—anti-cancer properties—induced cell death through apoptosis (in vitro) iso C15:0—inhibition of tumor growth in mice (in vivo) iso C15:0—induction of inhibitory effects on T-cell lymphomas in vitro and in vivo in mice | [ |
| OCFA |
decreased risk of coronary heart disease decreased risk of type 2 diabetes | [ |
| TFA |
not confirmed positive relationship between coronary heart disease and TFA of ruminant origin C18:1 C18:1 | [ |
|
reduced tumor growth decreased risk of coronary heart disease | [ | |
| C16:1 |
considered to be a lipokine released from adipose tissue that acts on distant organs mixed cardiovascular effects, direct or inverse correlations with obesity, hepatosteatosis, and a significant amelioration or prevention of insulin resistance and diabetes | [ |
| C18:1 |
anti-cancer and anti-atherogenic properties positive effect on cholesterol level improvement of immune response (anti-inflammatory effect) | [ |
| C18:2 n-6 |
improves sensitivity to insulin and thus reduces the incidence of type 2 diabetes | [ |
| CLnA |
inhibitory effect on cancer cell proliferation and growth of human tumor cells (in vitro) modification of lipid metabolism (with decreases in adipose tissue mass) in rodent models (in vivo) | [ |
| C18:1 n-11 |
beneficial modifying effect on the fluidity and permeability of cell membranes, regulates their metabolism, and may have anti-cancer properties | [ |
| AA |
neutralization of C12:0, C14:0 and C16:0 by increasing high-density lipoprotein cholesterol level anti-cancer, anti-hypertensive, and anti-inflammatory properties | [ |
| DHA |
positive effect on brain cells, which is important during remission of Alzheimer’s disease anti-cancer, anti-hypertensive, and anti-inflammatory properties | [ |
BCFA—branched-chain FAs; OCFA—odd-chain FAs; CLA—conjugated linoleic acid; c—cis; t—trans; C18:3 n-3—alfa-linolenic acid; C18:1 c9—oleic acid; C18:2 n-6—linoleic acid; CLnA—conjugated linolenic acids, mainly c9, t11, c15, and c9, t13; c15; C18:1 t11—vaccenic acid; AA—arachidonic acid; EPA—eicosapentaenoic acid; DHA—docosahexaenoic acid.